Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Invest Dermatol ; 141(8): 1995-2005.e6, 2021 08.
Article in English | MEDLINE | ID: mdl-33577766

ABSTRACT

Pro and anti-inflammatory B-cell subsets that localize to unperturbed and inflamed skin are newly emerging components of the skin immune system. To test the relevance of regulatory B cells (Bregs) in the suppression of cutaneous inflammation, we asked whether impaired migration of these cells into the skin exacerbates skin inflammation. Using a mouse model with a B-cell‒specific tamoxifen-inducible deletion of α4ß1 integrin, we demonstrate that selective disruption of α4ß1-integrin expression in B cells significantly decreases IL-10+ Bregs in inflamed skin, whereas it does not affect their counterparts in lymphoid tissues. Impaired skin homing and reduced cutaneous accumulation of IL-10+ Bregs lead to a significant increase in clinical and histopathological parameters of inflammation in both psoriasiform skin inflammation and cutaneous delayed contact hypersensitivity. Thus, our data show a crucial function of skin-homing IL-10+ Bregs in the suppression of skin inflammation, supporting the notion that Bregs are critical players in the cutaneous environment during inflammatory skin diseases.


Subject(s)
B-Lymphocytes, Regulatory/immunology , Cell Movement/immunology , Dermatitis/immunology , Psoriasis/immunology , Skin/pathology , Animals , B-Lymphocytes, Regulatory/metabolism , Dermatitis/pathology , Disease Models, Animal , Female , Humans , Imiquimod/administration & dosage , Imiquimod/immunology , Interleukin-10/metabolism , Male , Mice , Psoriasis/pathology , Skin/cytology , Skin/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...